Centella AsiaticavsMadecassoside

The four key triterpenoid saponins—madecassoside, asiaticoside, madecassic acid, and asiatic acid—exert distinct but complementary mechanisms. Madecassoside and asiaticoside are anti-inflammatory: they inhibit NF-κB nuclear translocation and IκB kinase activity, reducing TNF-α, IL-6, and IL-1β production in keratinocytes and dermal cells. Madecassic acid and asiatic acid (the aglycone forms) stimulate type I and III collagen synthesis in fibroblasts by upregulating collagen gene expression and procollagen production. All four compounds promote wound healing by stimulating angiogenesis via VEGF (vascular endothelial growth factor) upregulation, fibroblast proliferation and migration, and extracellular matrix remodeling. Centella extracts also increase superoxide dismutase (SOD) and catalase activity in skin cells, enhancing endogenous antioxidant defense. The triterpenes may modulate TGF-β and Smad signaling. TECA (Titrated Extract of Centella Asiatica) standardizes these actives for consistent clinical efficacy.

Madecassoside (triterpene glycoside from Centella asiatica) inhibits NF-kappa B nuclear translocation by preventing I-kappa B alpha degradation, suppressing transcription of pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6) and COX-2. Activates Nrf2, upregulating antioxidant enzymes (heme oxygenase-1, NQO1, glutathione peroxidase). Stimulates collagen type I synthesis through TGF-beta/Smad3 signaling in fibroblasts, upregulating COL1A1. Promotes keratinocyte migration (wound closure) by enhancing integrin expression and matrix metalloproteinase activity. Inhibits hyaluronidase, preserving skin hyaluronic acid. Reduces VEGF expression, inhibits MMP-1. Comprehensive: anti-inflammatory, antioxidant, pro-collagen, wound-healing. Used in pharmaceutical wound care (Madecassol) and K-beauty. Ideal for post-procedure recovery, retinoid irritation, sensitive skin.